glp-1 agonists and sglt2 inhibitors Receptor in Diabetic Kidney Disease: Evolving Evidence and Clinical Application SGLT-2 Inhibitors and GLP-1 Agonists:

Among the differentially expressed genes, 58 modules were identified as closely associated with microglial GLP-1R pathways and features of nerve injury, including pain hypersensitivity, ligation, paw withdrawal latency, and anxiety-related behaviors [64]

Definitions of long-term weight regain and their associations with clinical outcomes

9 Another case of exposure to dulaglutide during the first trimester of pregnancy for the treatment of type 2 diabetes did not result in any reported birth defects

A second paper, published in 1987, was a landmark: The tests showed that GLP-1 led to insulin secretion

[DOI] [PMC free article] [PubMed] [Google Scholar] 92.Chen D, Li Q, Liang H, Huang L, Zhou H, Zheng X, et al